1. Home
  2. CIVI vs TLX Comparison

CIVI vs TLX Comparison

Compare CIVI & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIVI
  • TLX
  • Stock Information
  • Founded
  • CIVI 1999
  • TLX 2015
  • Country
  • CIVI United States
  • TLX Australia
  • Employees
  • CIVI N/A
  • TLX N/A
  • Industry
  • CIVI Oil & Gas Production
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIVI Energy
  • TLX Health Care
  • Exchange
  • CIVI Nasdaq
  • TLX Nasdaq
  • Market Cap
  • CIVI 3.3B
  • TLX 6.0B
  • IPO Year
  • CIVI 2011
  • TLX N/A
  • Fundamental
  • Price
  • CIVI $32.63
  • TLX $16.99
  • Analyst Decision
  • CIVI Buy
  • TLX Strong Buy
  • Analyst Count
  • CIVI 10
  • TLX 1
  • Target Price
  • CIVI $68.50
  • TLX $22.00
  • AVG Volume (30 Days)
  • CIVI 2.6M
  • TLX 62.8K
  • Earning Date
  • CIVI 05-01-2025
  • TLX 01-01-0001
  • Dividend Yield
  • CIVI 12.32%
  • TLX N/A
  • EPS Growth
  • CIVI N/A
  • TLX 798.14
  • EPS
  • CIVI 8.46
  • TLX 0.09
  • Revenue
  • CIVI $5,206,808,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • CIVI N/A
  • TLX N/A
  • Revenue Next Year
  • CIVI $3.37
  • TLX N/A
  • P/E Ratio
  • CIVI $3.86
  • TLX $193.89
  • Revenue Growth
  • CIVI 49.65
  • TLX 55.85
  • 52 Week Low
  • CIVI $31.69
  • TLX $14.01
  • 52 Week High
  • CIVI $78.63
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • CIVI 28.10
  • TLX N/A
  • Support Level
  • CIVI $31.69
  • TLX N/A
  • Resistance Level
  • CIVI $35.60
  • TLX N/A
  • Average True Range (ATR)
  • CIVI 2.20
  • TLX 0.00
  • MACD
  • CIVI -0.51
  • TLX 0.00
  • Stochastic Oscillator
  • CIVI 5.18
  • TLX 0.00

About CIVI Civitas Resources Inc.

Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: